v3.22.1
Condensed Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Common Shares
Pre-funded warrants
Additional paid-in capital
Cumulative translation adjustment
Accumulated deficit
Total
Increase (Decrease) in Stockholders' Equity and Temporary Equity            
Number of warrants   11,417,034        
Beginning balance at Dec. 31, 2020 $ 251,682 $ 48,007 $ 8,530 $ (1,634) $ (163,466) $ 143,119
Balance at the beginning of period (in shares) at Dec. 31, 2020 29,827,997          
Increase (Decrease) in Stockholders' Equity and Temporary Equity            
Net loss         (12,514) (12,514)
Exercise of stock options (Note 6) $ 34   (15)     19
Exercise of stock options (note 6) (in shares) 18,003          
Share-based compensation (note 6)     1,368     1,368
Ending balance at Mar. 31, 2021 $ 251,716 $ 48,007 9,883 (1,634) (175,980) $ 131,992
Balance at the end of period (in shares) at Mar. 31, 2021 29,846,000          
Increase (Decrease) in Stockholders' Equity and Temporary Equity            
Number of warrants   11,417,034        
Number of warrants   12,327,780       12,327,780
Beginning balance at Dec. 31, 2021 $ 251,901 $ 52,941 15,711 (1,634) (206,319) $ 112,600
Balance at the beginning of period (in shares) at Dec. 31, 2021 29,897,559         29,897,559
Increase (Decrease) in Stockholders' Equity and Temporary Equity            
Net loss         (14,007) $ (14,007)
Exercise of stock options (Note 6) $ 89   (40)     49
Exercise of stock options (note 6) (in shares) 19,767          
Share-based compensation (note 6)     2,114     2,114
Ending balance at Mar. 31, 2022 $ 251,990 $ 52,941 $ 17,785 $ (1,634) $ (220,326) $ 100,756
Balance at the end of period (in shares) at Mar. 31, 2022 29,917,326         29,917,326
Increase (Decrease) in Stockholders' Equity and Temporary Equity            
Number of warrants   12,327,780       12,327,780